ReviewMaterials (Basel, Switzerland)2011
Advances in High-Field BOLD fMRI.
Review in Materials (Basel, Switzerland), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Apparent Diffusion Coefficient fMRI shines light on white matter resting-state connectivity compared to BOLD.Communications biology · 2025Article
- Modeling venous bias in resting state functional MRI metrics.Human brain mapping · 2023Article
- Resting-state functional connectivity in adults with 47,XXX: a 7 Tesla MRI study.Cerebral cortex (New York, N.Y. : 1991) · 2023Article
- Functional MRI in major depressive disorder: A review of findings, limitations, and future prospects.Journal of neuroimaging : official journal of the American Society of Neuroimaging · 2022Review
- New avenues for functional neuroimaging: ultra-high field MRI and OPM-MEG.Psychoradiology · 2021Review
- Neural substrates of early executive function development.Developmental review : DR · 2019Review
- Visualizing the Human Subcortex Using Ultra-high Field Magnetic Resonance Imaging.Brain topography · 2018Review
- Delineation of Tumor Habitats based on Dynamic Contrast Enhanced MRI.Scientific reports · 2017Article
- BOLD fMRI signal characteristics of S1- and S2-SSFP at 7 Tesla.Frontiers in neuroscience · 2014Article
- Modeling and suppression of respiration induced B0-fluctuations in non-balanced steady-state free precession sequences at 7 Tesla.Magma (New York, N.Y.) · 2013Article
- Single-shot echo-planar imaging with Nyquist ghost compensation: interleaved dual echo with acceleration (IDEA) echo-planar imaging (EPI).Magnetic resonance in medicine · 2013Article
- Applying independent component analysis to clinical FMRI at 7 t.Frontiers in human neuroscience · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This review article examines the current state of BOLD fMRI at a high magnetic field strength of 7 Tesla. The following aspects are covered: a short description of the BOLD contrast, spatial and temporal resolution, BOLD sensitivity, localization and spatial specificity, technical challenges as well as an outlook on future developments are given. It is shown that the main technical challenges of performing BOLD fMRI at high magnetic field strengths-namely development of array coils, imaging sequences and parallel imaging reconstruction-have been solved successfully. The combination of these developments has lead to the availability of high-resolution BOLD fMRI protocols that are able to cover the whole brain with a repetition time (TR) shorter than 3 s. The structural information available from these high-resolution fMRI images itself is already very detailed, which helps to co-localize structure and function. Potential future applications include whole-brain connectivity analysis on a laminar resolution and single subject examinations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.